2000
DOI: 10.1016/s0957-4166(00)00081-1
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of enantiomerically pure 4-aryl-3,4-dihydropyrimidin-2(1 H )-ones via enzymatic resolution: preparation of the antihypertensive agent ( R )-SQ 32926 †Synthesis and reactions of Biginelli compounds, part 20; for part 19, see: Kappe, C. O.; Shishkin, O. V.; Uray, G.; Verdino, P. Tetrahedron 2000, 56, 1859–1862. †

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(25 citation statements)
references
References 17 publications
0
25
0
Order By: Relevance
“…Chemical resolution and enzymatic strategies are traditional methods to prepare optically pure DHPMs [14,15]. Nevertheless, the catalytic asymmetric Biginelli reaction has rarely been reported.…”
mentioning
confidence: 99%
“…Chemical resolution and enzymatic strategies are traditional methods to prepare optically pure DHPMs [14,15]. Nevertheless, the catalytic asymmetric Biginelli reaction has rarely been reported.…”
mentioning
confidence: 99%
“…In the absence of any known general asymmetric synthesis for this heterocyclic target system, resolution strategies have so far been the method of choice to rapidly obtain enantiomerically pure DHPMs. These methods include fractional crystallization techniques involving diastereomeric a-methylbenzylammonium salts [60] or covalently linked derivatives [12,56,61], or rely on biocatalytic resolution [62]. Analytically, separation of DHPM derivatives can be readily achieved by enantioselective HPLC using a variety of different chiral stationary phases (CSPs) [63], including ™designer-made∫ CSPs that are based on the principle of ™reciprocal∫ recognition of chirality using the immobilized DHPM derivative 38 (Scheme 11) [24].…”
Section: Chirality and Biological Activitymentioning
confidence: 99%
“…benzene: ethyl acetate (9:1), benzene: ethyl acetate: Methanol (8.5:1.4:0.1). IR spectra were recorded in KBr on a Perkin Elmer Infrared RXI FTIR spectrophotometer and 1 H NMR spectra were recorded on Bruker Avance II 400 NMR Spectrometer using DMSO-d 6 and CDCl 3 as solvent and tetramethylsilane (TMS) as internal reference standard. All the compounds (4a-m) were synthesized by both the methods and it was observed that yield of the compound obtained by Method B is high as compared to that obtained by Method A (Table 1 c h l o r o p h e n y l ) -1 , 2 , 3 , 4 1 , 2 , 3 E t h y l -6 -m e t h y l -2 -o x o -4 -( 3 , 4 -d i m e t h o x y p h e n y l ) -1 , 2 , 3 , 4 -tetrahydropyrimidin-5-carboxylate (4i) -6 -m e t h y l -2 -o x o -4 -( 2 -h y d r o x y p h e n y l ) -1 , 2 , 3 , 4 c h l o r o p h e n y l ) -1 , 2 , 3 …”
Section: Methodsmentioning
confidence: 99%
“…The 3,4-dihydropyrimidin-2-(1H)-ones (DHPM's) have recently emerged as important target molecules due to their therapeutic and pharmacological properties 2 such as antiviral 3 , antimitotic 4 , anticarcinogenic 5 , antihypertensive 6 and noteworthy, as calcium channel modulators. 7 Owing to the immense therapeutic and medicinal significance of DHPM's, exploring convenient and efficient methods for their synthesis with readily available reagents is of prime importance.…”
Section: Introductionmentioning
confidence: 99%